Intervention not reported
Non‐relapse mortality (at 36 months) · patients after allogeneic stem cell or bone marrow transplantation
The intervention showed no clear difference in non‐relapse mortality (at 36 months) (moderate certainty).
1 finding from 1 review
- Polyclonal anti‐thymocyte globulins for the prophylaxis of graft‐versus‐host disease after allogeneic stem cell or… 2023 · Cochrane Headline outcomes onlyHR 0.86 [0.67, 1.11]9 studies · 1370 participantsModerate